Joshua D. Schiffman, MD

Journal Article

1. Middleton EA, He XY, Denorme F, Campbell RA, Ng D, Salvatore SP, Mostyka M, Baxter-Stoltzfus A, Borczuk AC, Loda M, Cody MJ, Manne BK, Portier I, Harris ES, Petrey AC, Beswick EJ, Caulin AF, Iovino A, Abegglen LM, Weyrich AS, Rondina MT, Egeblad M, Schiffman JD, Yost C (2020). Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome. Blood, 136(10), 1169-1179. (Read full publication)
2. Vasconcelos GM, Kang M, Pombo-de-Oliveira MS, Schiffman JD, Lorey F, Buffler P, Wiemels J (2008). Adenovirus detection in Guthrie cards from paediatric leukaemia cases and controls. British journal of cancer, 99(10), 1668-72. (Read full publication)
3. Jones KB, Schiffman JD, Kohlmann W, Randall RL, Lessnick SL, Cannon-Albright L (2011). Complex genotype sarcomas display familial inheritance independent of known cancer predisposition syndromes. Cancer epidemiology, biomarkers & prevention, 20(5), 751-7. (Read full publication)
4. Mai PL, Sand SR, Saha N, Oberti M, Dolafi T, DiGianni L, Root EJ, Kong X, Bremer RC, Santiago KM, Bojadzieva J, Barley D, Novokmet A, Ketchum KA, Nguyen N, Jacob S, Nichols KE, Kratz CP, Schiffman JD, Evans DG, Achatz MI, Strong LC, Garber JE, Ladwa SA, Malkin D, Weitzel J (2020). Li-Fraumeni Exploration Consortium Data Coordinating Center: Building an Interactive Web-Based Resource for Collaborative International Cancer Epidemiology Research for a Rare Condition. Cancer epidemiology, biomarkers & prevention, 29(5), 927-935. (Read full publication)
5. Fedak EA, Adler FR, Abegglen LM, Schiffman J (2021). ATM and ATR Activation Through Crosstalk Between DNA Damage Response Pathways. Bulletin of mathematical biology, 83(4), 38. (Read full publication)
6. Fortuno C, Mester J, Pesaran T, Weitzel JN, Dolinsky J, Yussuf A, McGoldrick K, Garber JE, Savage SA, Khincha PP, Gareth Evans D, Achatz MI, Nichols KE, Maxwell KN, Schiffman JD, Sandoval R, Li-Fraumeni Exploration (LIFE) Consortium., James PA, Spurdle A (2020). Suggested application of HER2+ breast tumor phenotype for germline TP53 variant classification within ACMG/AMP guidelines. Human mutation, 41(9), 1555-1562. (Read full publication)
7. Maxwell KN, Cheng HH, Powers J, Gulati R, Ledet EM, Morrison C, Le A, Hausler R, Stopfer J, Hyman S, Kohlmann W, Naumer A, Vagher J, Greenberg SE, Naylor L, Laurino M, Konnick EQ, Shirts BH, AlDubayan SH, Van Allen EM, Nguyen B, Vijai J, Abida W, Carlo MI, Dubard-Gault M, Lee DJ, Maese LD, Mandelker D, Montgomery B, Morris MJ, Nicolosi P, Nussbaum RL, Schwartz LE, Stadler Z, Garber JE, Offit K, Schiffman JD, Nelson PS, Sartor O, Walsh MF, Pritchard C (2021). Inherited TP53 Variants and Risk of Prostate Cancer. European urology, 81, 243-250. (Read full publication)
8. Spector LG, Hubbard AK, Diessner BJ, Machiela MJ, Webber BR, Schiffman J (2021). Comparative international incidence of Ewing sarcoma 1988 to 2012. International journal of cancer, 149(5), 1054-1066. (Read full publication)
9. Li H, Sisoudiya SD, Martin-Giacalone BA, Khayat MM, Dugan-Perez S, Marquez-Do DA, Scheurer ME, Muzny D, Boerwinkle E, Gibbs RA, Chi YY, Barkauskas DA, Lo T, Hall D, Stewart DR, Schiffman JD, Skapek SX, Hawkins DS, Plon SE, Sabo A, Lupo P (2021). Germline Cancer Predisposition Variants in'Pediatric Rhabdomyosarcoma: A Report From the Children's Oncology Group. Journal of the National Cancer Institute, 113(7), 875-883. (Read full publication)
10. Weldon CB, Madenci AL, Boikos SA, Janeway KA, George S, von Mehren M, Pappo AS, Schiffman JD, Wright J, Trent JC, Pacak K, Stratakis CA, Helman LJ, La Quaglia M (2017). Surgical Management of Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Pediatric and Wildtype GIST Clinic. Journal of clinical oncology, 35(5), 523-528. (Read full publication)
11. Tollis M, Ferris E, Campbell MS, Harris VK, Rupp SM, Harrison TM, Kiso WK, Schmitt DL, Garner MM, Aktipis CA, Maley CC, Boddy AM, Yandell M, Gregg C, Schiffman JD, Abegglen L (2021). Elephant Genomes Reveal Accelerated Evolution in Mechanisms Underlying Disease Defenses. Molecular biology and evolution, 38(9), 3606-3620. (Read full publication)
12. Bouck EG, Denorme F, Holle LA, Middelton EA, Blair AM, de Laat B, Schiffman JD, Yost CC, Rondina MT, Wolberg AS, Campbell R (2021). COVID-19 and Sepsis Are Associated With Different Abnormalities in Plasma Procoagulant and Fibrinolytic Activity. Arteriosclerosis, thrombosis, and vascular biology, 41(1), 401-414. (Read full publication)
13. Meeker ND, Yang JJ, Schiffman J (2010). Pharmacogenomics of pediatric acute lymphoblastic leukemia. Expert opinion on pharmacotherapy, 11(10), 1621-32. (Read full publication)
14. Kaphingst KA, Kohlmann W, Chambers RL, Goodman MS, Bradshaw R, Chan PA, Chavez-Yenter D, Colonna SV, Espinel WF, Everett JN, Gammon A, Goldberg ER, Gonzalez J, Hagerty KJ, Hess R, Kehoe K, Kessler C, Kimball KE, Loomis S, Martinez TR, Monahan R, Schiffman JD, Temares D, Tobik K, Wetter DW, Mann DM, Kawamoto K, Del Fiol G, Buys SS, Ginsburg O, BRIDGE research team (2021). Comparing models of delivery for cancer genetics services among patients receiving primary care who meet criteria for genetic evaluation in two healthcare systems: BRIDGE randomized controlled trial. BMC health services research, 21(1), 542. (Read full publication)
15. Allen CG, Ritchie JB, Morrison H, Lauzon SD, Nichols M, Schiffman JD, Hughes Halbert C, Welch B (2021). A thematic analysis of health information technology use among cancer genetic counselors. Journal of genetic counseling, 30(1), 170-179. (Read full publication)
16. Tak CR, Biltaji E, Kohlmann W, Maese L, Hainaut P, Villani A, Malkin D, Sherwin CMT, Brixner DI, Schiffman J (2019). Cost-effectiveness of early cancer surveillance for patients with Li-Fraumeni syndrome. Pediatric blood & cancer, 66(5), e27629. (Read full publication)
17. Meyer JA, Zhou D, Mason CC, Downie JM, Rodic V, Abromowitch M, Wistinghausen B, Termuhlen AM, Angiolillo AL, Perkins SL, Lones MA, Barnette P, Schiffman JD, Miles R (2017). Genomic characterization of pediatric B-lymphoblastic lymphoma and B-lymphoblastic leukemia using formalin-fixed tissues. Pediatric blood & cancer, 64(7), (Read full publication)
18. Welch BM, O'Connell NS, Qanungo S, Halbert-Hughes C, Schiffman J (2015). Collecting Family Health History using an Online Social Network: a Nationwide Survey among Potential Users. AMIA ... Annual Symposium proceedings. AMIA Symposium, 2015, 1316-25. (Read full publication)
19. Pearson VR, Bosse JB, Koyuncu OO, Scherer J, Toruno C, Robinson R, Abegglen LM, Schiffman JD, Enquist LW, Rall G (2021). Identification of African Elephant Polyomavirus in wild elephants and the creation of a vector expressing its viral tumor antigens to transform elephant primary cells. PloS one, 16(2), e0244334. (Read full publication)
20. Mowery DL, Kawamoto K, Bradshaw R, Kohlmann W, Schiffman JD, Weir C, Borbolla D, Chapman WW, Del Fiol (2019). Determining Onset for Familial Breast and Colorectal Cancer from Family History Comments in the Electronic Health Record. AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science, 2019, 173-181. (Read full publication)
21. Abbott D, O'Brien S, Farnham JM, Young EL, Yap J, Jones K, Lessnick SL, Randall RL, Schiffman JD, Cannon-Albright L (2019). Increased risk for other cancers in individuals with Ewing sarcoma and their relatives. Cancer medicine, 8(18), 7924-7930. (Read full publication)
22. Ritchie JB, Allen CG, Morrison H, Nichols M, Lauzon SD, Schiffman JD, Hughes Halbert C, Welch B (2020). Utilization of health information technology among cancer genetic counselors. Molecular genetics & genomic medicine, 8(8), e1315. (Read full publication)
23. Boddy AM, Abegglen LM, Pessier AP, Aktipis A, Schiffman JD, Maley CC, Witte (2020). Lifetime cancer prevalence and life history traits in mammals. Evolution, medicine, and public health, 2020(1), 187-195. (Read full publication)
24. Lupo PJ, Schraw JM, Desrosiers TA, Nembhard WN, Langlois PH, Canfield MA, Copeland G, Meyer RE, Brown AL, Chambers TM, Sok P, Danysh HE, Carozza SE, Sisoudiya SD, Hilsenbeck SG, Janitz AE, Oster ME, Scheuerle AE, Schiffman JD, Luo C, Mian A, Mueller BA, Huff CD, Rasmussen SA, Scheurer ME, Plon S (2019). Association Between Birth Defects and Cancer Risk Among Children and Adolescents in a Population-Based Assessment of 10 Million Live Births. JAMA oncology, 5(8), 1150-1158. (Read full publication)
25. Mangum DS, Meyer JA, Mason CC, Shams S, Maese LD, Gardiner JD, Downie JM, Pei D, Cheng C, Gleason A, Luo M, Pui CH, Aplenc R, Hunger SP, Loh M, Greaves M, Trede N, Raetz E, Frazer JK, Mullighan CG, Engel ME, Miles RR, Rabin KR, Schiffman J (2021). Association of Combined Focal 22q11.22 Deletion and IKZF1 Alterations With Outcomes in Childhood Acute Lymphoblastic Leukemia. JAMA oncology, 7(10), 1521-1528. (Read full publication)
26. Colonna S, Curtin K, Johnson E, Kohlmann W, Wright J, Kirchhoff A, Tavtigian S, Schiffman (2019). Family History of Breast Cancer Associated with Breast Cancer in Survivors of Hodgkin Lymphoma. International journal of cancer and clinical research, 6(1), (Read full publication)
27. Dubard Gault M, Mandelker D, DeLair D, Stewart CR, Kemel Y, Sheehan MR, Siegel B, Kennedy J, Marcell V, Arnold A, Al-Ahmadie H, Modak S, Robson M, Shukla N, Roberts S, Vijai J, Topka S, Kentsis A, Cadoo K, Carlo M, Latham Schwark A, Reznik E, Dinatale R, Hechtman J, Borras Flores E, Jairam S, Yang C, Li Y, Bayraktar EC, Ceyhan-Birsoy O, Zhang L, Kohlman W, Schiffman J, Stadler Z, Birsoy K, Kung A, Offit K, Walsh M (2018). Germline SDHA mutations in children and adults with cancer. Cold Spring Harbor molecular case studies, 4(4), (Read full publication)
28. Kim J, Light N, Subasri V, Young EL, Wegman-Ostrosky T, Barkauskas DA, Hall D, Lupo PJ, Patidar R, Maese LD, Jones K, Wang M, Tavtigian SV, Wu D, Shlien A, Telfer F, Goldenberg A, Skapek SX, Wei JS, Wen X, Catchpoole D, Hawkins DS, Schiffman JD, Khan J, Malkin D, Stewart D (2021). Pathogenic Germline Variants in Cancer Susceptibility Genes in Children and Young Adults With Rhabdomyosarcoma. JCO precision oncology, 5, (Read full publication)
29. Del Fiol G, Kohlmann W, Bradshaw RL, Weir CR, Flynn M, Hess R, Schiffman JD, Nanjo C, Kawamoto (2020). Standards-Based Clinical Decision Support Platform to Manage Patients Who Meet Guideline-Based Criteria for Genetic Evaluation of Familial Cancer. JCO clinical cancer informatics, 4, 1-9. (Read full publication)
30. Welch BM, Allen CG, Ritchie JB, Morrison H, Hughes-Halbert C, Schiffman J (2020). Using a Chatbot to Assess Hereditary Cancer Risk. JCO clinical cancer informatics, 4, 787-793. (Read full publication)
31. Aziz A, Pflieger L, O'Connell N, Schiffman J, Welch B (2017). Compatibility of Family History Cancer Guidelines With Meaningful Use Standards. JCO clinical cancer informatics, 1, (Read full publication)
32. Taber P, Ghani P, Schiffman JD, Kohlmann W, Hess R, Chidambaram V, Kawamoto K, Waller RG, Borbolla D, Del Fiol G, Weir (2020). Physicians' strategies for using family history data: having the data is not the same as using the data. JAMIA open, 3(3), 378-385. (Read full publication)
33. Pedersen BS, Brown JM, Dashnow H, Wallace AD, Velinder M, Tristani-Firouzi M, Schiffman JD, Tvrdik T, Mao R, Best DH, Bayrak-Toydemir P, Quinlan A (2021). Effective variant filtering and expected candidate variant yield in studies of rare human disease. NPJ genomic medicine, 6(1), 60. (Read full publication)
34. Ritchie JB, Bellcross C, Allen CG, Frey L, Morrison H, Schiffman JD, Welch B (2021). Evaluation and comparison of hereditary Cancer guidelines in the population. Hereditary cancer in clinical practice, 19(1), 31. (Read full publication)
35. Ritchie JB, Frey LJ, Lamy JB, Bellcross C, Morrison H, Schiffman JD, Welch B (2022). Automated Clinical Practice Guideline Recommendations for Hereditary Cancer Risk Using Chatbots and Ontologies: System Description. JMIR cancer, 8(1), e29289. (Read full publication)
36. Schienda J, Church AJ, Corson LB, Decker B, Clinton CM, Manning DK, Imamovic-Tuco A, Reidy D, Strand GR, Applebaum MA, Bagatell R, DuBois SG, Glade-Bender JL, Kang W, Kim A, Laetsch TW, Macy ME, Maese L, Pinto N, Sabnis AJ, Schiffman JD, Colace SI, Volchenboum SL, Weiser DA, Nowak JA, Lindeman NI, Janeway KA, Crompton BD, Kamihara (2021). Germline Sequencing Improves Tumor-Only Sequencing Interpretation in a Precision Genomic Study of Patients With Pediatric Solid Tumor. JCO precision oncology, 5, (Read full publication)
37. Ritchie JB, Welch BM, Allen CG, Frey LJ, Morrison H, Schiffman JD, Alekseyenko AV, Dean B, Hughes Halbert C, Bellcross (2021). Comparison of a Cancer Family History Collection and Risk Assessment Tool - ItRunsInMyFamily - with Risk Assessment by Health-Care Professionals. Public health genomics, 1-9. (Read full publication)
38. Gillani R, Camp SY, Han S, Jones JK, Chu H, O'Brien S, Young EL, Hayes L, Mitchell G, Fowler T, Gusev A, Kamihara J, Janeway KA, Schiffman JD, Crompton BD, AlDubayan SH, Van Allen E (2022). Germline predisposition to pediatric Ewing sarcoma is characterized by inherited pathogenic variants in DNA damage repair genes. American journal of human genetics, (Read full publication)
39. Compton ZT, Vincze O, Mellon W, Tollis M, Abegglen L, Schiffman JD, Giraudeau M, Boddy AM, Maley C (2025). Paradoxical indeed. Proceedings of the National Academy of Sciences of the United States of America, 122(19), e2504512122. (Read full publication)
40. Hashibe M, Herget KA, Schiffman JD, Chang V (2025). Disparities in childhood leukemia survival for Asian, Native Hawaiian, and Pacific Islanders in the United States. International journal of cancer, 156(8), 1563-1571. (Read full publication)
41. Compton ZT, Mellon W, Harris VK, Rupp S, Mallo D, Kapsetaki SE, Wilmot M, Kennington R, Noble K, Baciu C, Ramirez LN, Peraza A, Martins B, Sudhakar S, Aksoy S, Furukawa G, Vincze O, Giraudeau M, Duke EG, Spiro S, Flach E, Davidson H, Li CI, Zehnder A, Graham TA, Troan BV, Harrison TM, Tollis M, Schiffman JD, Aktipis CA, Abegglen LM, Maley CC, Boddy A (2025). Cancer Prevalence across Vertebrates. Cancer discovery, 15(1), 227-244. (Read full publication)
42. Fiorica PN, Golmard L, Kim J, Bao R, Lin FY, Roy A, Pribnow A, Perrino MR, Masliah-Planchon J, Michalak-Provost S, Wong J, Filser M, Stoppa-Lyonnet D, Bourdeaut F, Brahimi A, Ingster O, Saulnier Sholler G, Jackson SA, Sasaki MM, Fowler T, Ng A, Corbett RJ, Kaufman RS, Haley JS, Carey DJ, Huang KL, Diskin SJ, Rokita JL, Al-Kateb H, McGee RB, Schiffman JD, Chen KS, Stewart DR, Williams Parsons D, Plon SE, Schultz KAP, Onel (2025). Germline Pathogenic DROSHA Variants Are Linked to Pineoblastoma and Wilms Tumor Predisposition. Clinical cancer research, 31(8), 1491-1503. (Read full publication)
43. Firsanov D, Zacher M, Tian X, Sformo TL, Zhao Y, Tombline G, Lu JY, Zheng Z, Perelli L, Gurreri E, Zhang L, Guo J, Korotkov A, Volobaev V, Biashad SA, Zhang Z, Heid J, Maslov A, Sun S, Wu Z, Gigas J, Hillpot E, Martinez J, Lee M, Williams A, Gilman A, Hamilton N, Haseljic E, Patel A, Straight M, Miller N, Ablaeva J, Tam LM, Couderc C, Hoopman M, Moritz R, Fujii S, Hayman DJ, Liu H, Cai Y, Leung AKL, Simons MJP, Zhang Z, Nelson CB, Abegglen LM, Schiffman JD, Gladyshev VN, Modesti M, Genovese G, Vijg J, Seluanov A, Gorbunova (2024). DNA repair and anti-cancer mechanisms in the long-lived bowhead whale. bioRxiv, (Read full publication)
44. Kaphingst KA, Kohlmann WK, Lorenz Chambers R, Bather JR, Goodman MS, Bradshaw RL, Chavez-Yenter D, Colonna SV, Espinel WF, Everett JN, Flynn M, Gammon A, Harris A, Hess R, Kaiser-Jackson L, Lee S, Monahan R, Schiffman JD, Volkmar M, Wetter DW, Zhong L, Mann DM, Ginsburg O, Sigireddi M, Kawamoto K, Del Fiol G, Buys S (2024). Uptake of Cancer Genetic Services for Chatbot vs Standard-of-Care Delivery Models: The BRIDGE Randomized Clinical Trial. JAMA network open, 7(9), e2432143. (Read full publication)
45. Kapsetaki SE, Compton ZT, Mellon W, Vincze O, Giraudeau M, Harrison TM, Abegglen LM, Boddy AM, Maley CC, Schiffman J (2024). Germline mutation rate predicts cancer mortality across 37 vertebrate species. Evolution, medicine, and public health, 12(1), 122-128. (Read full publication)
46. Soni H, Morrison H, Vasilev D, Ong T, Wilczewski H, Allen C, Hughes-Halbert C, Ritchie JB, Narma A, Schiffman JD, Ivanova J, Bunnell BE, Welch B (2024). User experience of a family health history chatbot: A quantitative analysis. Health informatics journal, 30(2), 14604582241262251. (Read full publication)
47. Martin-Giacalone BA, Li H, Scheurer ME, Casey DL, Dugan-Perez S, Marquez-Do DA, Muzny D, Gibbs RA, Barkauskas DA, Hall D, Stewart DR, Schiffman JD, McEvoy MT, Khan J, Malkin D, Linardic CM, Crompton BD, Shern JF, Skapek SX, Venkatramani R, Hawkins DS, Sabo A, Plon SE, Lupo P (2024). Germline Genetic Testing and Survival Outcomes Among Children With Rhabdomyosarcoma: A Report From the Children's Oncology Group. JAMA network open, 7(3), e244170. (Read full publication)
48. Mansur MB, deSouza NM, Natrajan R, Abegglen LM, Schiffman JD, Greaves (2023). Evolutionary determinants of curability in cancer. Nature ecology & evolution, 7(11), 1761-1770. (Read full publication)
49. Krinsky N, Sizikov S, Nissim S, Dror A, Sas A, Prinz H, Pri-Or E, Perek S, Raz-Pasteur A, Lejbkowicz I, Cohen-Matsliah SI, Almog R, Chen N, Kurd R, Jarjou'i A, Rokach A, Ben-Chetrit E, Schroeder A, Caulin AF, Yost CC, Schiffman JD, Goldfeder M, Martinod (2023). NETosis induction reflects COVID-19 severity and long COVID: insights from a 2-center patient cohort study in Israel. Journal of thrombosis and haemostasis, 21(9), 2569-2584. (Read full publication)
50. Compton ZT, Harris V, Mellon W, Rupp S, Mallo D, Kapsetaki SE, Wilmot M, Kennington R, Noble K, Baciu C, Ramirez L, Peraza A, Martins B, Sudhakar S, Aksoy S, Furukawa G, Vincze O, Giraudeau M, Duke EG, Spiro S, Flach E, Davidson H, Zehnder A, Graham TA, Troan B, Harrison TM, Tollis M, Schiffman JD, Aktipis A, Abegglen LM, Maley CC, Boddy A (2023). Cancer Prevalence Across Vertebrates. Research square, (Read full publication)
51. Fair D, Maese L, Chi YY, Li M, Hawkins DS, Venkatramani R, Rudzinski E, Parham D, Teot L, Malkin D, Plon SE, Li H, Sabo A, Lupo PJ, Schiffman J (2023). TP53 germline pathogenic variant frequency in anaplastic rhabdomyosarcoma: A Children's Oncology Group report. Pediatric blood & cancer, e30413. (Read full publication)
52. Choe JH, Kawase T, Xu A, Guzman A, Obradovic AZ, Low-Calle AM, Alaghebandan B, Raghavan A, Long K, Hwang PM, Schiffman JD, Zhu Y, Zhao R, Lee DF, Katz C, Prives (2023). Li-Fraumeni Syndrome-Associated Dimer-Forming Mutant p53 Promotes Transactivation-Independent Mitochondrial Cell Death. Cancer discovery, 13(5), 1250-1273. (Read full publication)
53. Subasri V, Light N, Kanwar N, Brzezinski J, Luo P, Hansford JR, Cairney E, Portwine C, Elser C, Finlay JL, Nichols KE, Alon N, Brunga L, Anson J, Kohlmann W, de Andrade KC, Khincha PP, Savage SA, Schiffman JD, Weksberg R, Pugh TJ, Villani A, Shlien A, Goldenberg A, Malkin (2023). Multiple Germline Events Contribute to Cancer Development in Patients with Li-Fraumeni Syndrome. Cancer research communications, 3(5), 738-754. (Read full publication)
54. Preston AJ, Rogers A, Sharp M, Mitchell G, Toruno C, Barney BB, Donovan LN, Bly J, Kennington R, Payne E, Iovino A, Furukawa G, Robinson R, Shamloo B, Buccilli M, Anders R, Eckstein S, Fedak EA, Wright T, Maley CC, Kiso WK, Schmitt D, Malkin D, Schiffman JD, Abegglen L (2023). Elephant TP53-RETROGENE 9 induces transcription-independent apoptosis at the mitochondria. Cell death discovery, 9(1), 66. (Read full publication)
55. Ballinger ML, Pattnaik S, Mundra PA, Zaheed M, Rath E, Priestley P, Baber J, Ray-Coquard I, Isambert N, Causeret S, van der Graaf WTA, Puri A, Duffaud F, Le Cesne A, Seddon B, Chandrasekar C, Schiffman JD, Brohl AS, James PA, Kurtz JE, Penel N, Myklebost O, Meza-Zepeda LA, Pickett H, Kansara M, Waddell N, Kondrashova O, Pearson JV, Barbour AP, Li S, Nguyen TL, Fatkin D, Graham RM, Giannoulatou E, Green MJ, Kaplan W, Ravishankar S, Copty J, Powell JE, Cuppen E, van Eijk K, Veldink J, Ahn JH, Kim JE, Randall RL, Tucker K, Judson I, Sarin R, Ludwig T, Genin E, Deleuze JF, French Exome Project Consortium, Haber M, Marshall G, Cairns MJ, Blay JY, International Sarcoma Kindred Study, Thomas DM, Tattersall M, Neuhaus S, Lewis C, Tucker K, Carey-Smith R, Wood D, Porceddu S, Dickinson I, Thorne H, James P, Ray-Coquard I, Blay JY, Cassier P, Le Cesne A, Duffaud F, Penel N, Isambert N, Kurtz JE, Puri A, Sarin R, Ahn JH, Kim JE, Ward I, Judson I, van der Graaf W, Seddon B, Chandrasekar C, Rickar R, Hennig I, Schiffman J, Randall RL, Silvestri A, Zaratzian A, Tayao M, Walwyn K, Niedermayr E, Mang D, Clark R, Thorpe T, MacDonald J, Riddell K, Mar J, Fennelly V, Wicht A, Zielony B, Galligan E, Glavich G, Stoeckert J, Williams L, Djandjgava L, Buettner I, Osinki C, Stephens S, Rogasik M, Bouclier L, Girodet M, Charreton A, Fayet Y, Crasto S, Sandupatla B, Yoon Y, Je N, Thompson L, Fowler T, Johnson B, Petrikova G, Hambridge T, Hutchins A, Bottero D, Scanlon D, Stokes-Denson J, Génin E, Campion D, Dartigues JF, Deleuze JF, Lambert JC, Redon R, Ludwig T, Grenier-Boley B, Letort S, Lindenbaum P, Meyer V, Quenez O, Dina C, Bellenguez C, Le Clézio CC, Giemza J, Chatel S, Férec C, Le Marec H, Letenneur L, Nicolas G, Rouault (2023). Heritable defects in telomere and mitotic function selectively predispose to sarcomas. Science (New York, N.Y.), 379(6629), 253-260. (Read full publication)
56. de Araujo CV, Denorme F, Stephens WZ, Li Q, Cody MJ, Crandell JL, Petrey AC, Queisser KA, Rustad JL, Fulcher JM, Evangelista JL, Kay MS, Schiffman JD, Campbell RA, Yost C (2023). Neonatal NET-Inhibitory Factor improves survival in the cecal ligation and puncture model of polymicrobial sepsis by inhibiting neutrophil extracellular traps. Frontiers in immunology, 13, 1046574. (Read full publication)
57. Light N, Layeghifard M, Attery A, Subasri V, Zatzman M, Anderson ND, Hatkar R, Blay S, Chen D, Novokmet A, Fuligni F, Tran J, de Borja R, Agarwal H, Waldman L, Abegglen LM, Albertson D, Finlay JL, Hansford JR, Behjati S, Villani A, Gerstung M, Alexandrov LB, Somers GR, Schiffman JD, Rotter V, Malkin D, Shlien (2023). Germline TP53 mutations undergo copy number gain years prior to tumor diagnosis. Nature communications, 14(1), 77. (Read full publication)
58. Kaneva K, Schurr TG, Tatarinova TV, Buckley J, Merkurjev D, Triska P, Liu X, Done J, Maglinte DT, Deapen D, Hwang A, Schiffman JD, Triche TJ, Biegel JA, Gai (2022). Mitochondrial DNA haplogroup, genetic ancestry, and susceptibility to Ewing sarcoma. Mitochondrion, 67, 6-14. (Read full publication)
59. MacFarland SP, Maese L, Rednam SP, Kamihara J, Perrino MR, Nichols KE, Brodeur GM, Schiffman JD, Plon SE, Diller LR, Malkin D, Porter CC, Villani (2022). Collaboration to Promote Research and Improve Clinical Care in the Evolving Field of Childhood Cancer Predisposition. Cancer prevention research (Philadelphia, Pa.), 15(10), 645-652. (Read full publication)
60. Abegglen LM, Harrison TM, Moresco A, Fowles JS, Troan BV, Kiso WK, Schmitt D, Boddy AM, Schiffman J (2022). Of Elephants and Other Mammals: A Comparative Review of Reproductive Tumors and Potential Impact on Conservation. Animals, 12(15), (Read full publication)
61. Schiffman J, Korr (2015). Josh Schiffman, MD: Genetic clues as to why elephants rarely get cancer. Providence native hopes research will help target pediatric cancers. Rhode Island medical journal (2013), 98(11), 80-2. (Read full publication)
62. Vagher J, Zakas A, Donovan L, Shoger K, Naumer A, Bly J, Smith-Simmer K, Maese L, Schiffman J, Kohlmann W, Garzon R, Churpek JE, Osman AE (2025). Hematologic Malignancy Frequency, Phenotypes, and Outcomes in Li-Fraumeni Syndrome. JCO precision oncology, 9, e2400860. (Read full publication)
63. Subasri V, Brew B, Laverty B, Erdman L, Guha T, Hansford JR, Cairney E, Portwine C, Elser C, Finlay JL, Nichols KE, Anson J, Kohlmann W, Gong H, Lees J, Alon N, Brunga L, Villani A, de Andrade KC, Khincha PP, Savage SA, Schiffman JD, Pugh TJ, Malkin D, Goldenberg (2025). Peripheral blood DNA methylation predicts the early onset of primary tumor in TP53 mutation carriers. Nature communications, 16(1), 7976. (Read full publication)
64. Vincze O, Spada B, Bilder D, Cagan A, DeGregori J, Gorbunova V, Maley CC, Schiffman JD, Seluanov A, Giraudeau M, Pradeu (2025). Advancing cancer research via comparative oncology. Nature reviews. Cancer, 25(9), 740-748. (Read full publication)

Review

1. Vincze O, Spada B, Bilder D, Cagan A, DeGregori J, Gorbunova V, Maley CC, Schiffman JD, Seluanov A, Giraudeau M, Pradeu (2025). Advancing cancer research via comparative oncology. Nature reviews. Cancer, 25(9), 740-748. (Read full publication)

Letter

1. Boddy AM, Abegglen LM, Aktipis A, Schiffman JD, Maley CC, Witte (2020). Does placental invasiveness lead to higher rates of malignant transformation in mammals?: Response to: 'Available data suggests positive relationship between placental invasion an malignancy'. Evolution, medicine, and public health, 2020(1), 215-216. (Read full publication)
2. Kratz CP, Villani A, Nichols KE, Schiffman J, Malkin (2020). Cancer surveillance for individuals with Li-Fraumeni syndrome. European journal of human genetics, 28(11), 1481-1482. (Read full publication)

Other

1. de Araujo CV, Denorme F, Stephens WZ, Li Q, Cody MJ, Crandell JL, Petrey AC, Queisser KA, Rustad JL, Fulcher JM, Evangelista JL, Kay MS, Schiffman JD, Campbell RA, Yost C (2023). Corrigendum: Neonatal NET-Inhibitory Factor improves survival in the cecal ligation and puncture model of polymicrobial sepsis by inhibiting neutrophil extracellular traps. Frontiers in immunology, 14, 1171222. (Read full publication)

News

• Clues to COVID-19 Complications Come from NET-like Inflammatory Response
• Why Elephants Rarely Get Cancer
• Charlton Park named UUHC’s new Chief Analytics Officer
• Vaginal Vs. Cesarean Delivery

Podcasts

• Obtaining An Accurate Family Health History is Crucial
• What Elephants Can Teach Us About Evading Cancer
• An Initiative to Prevent Childhood Cancer Before it Starts
• Knowing the Difference Between Inherited and Acquired Cancers Can Save Lives